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Pre-corneal tear film thickness in humans measured with a novel
technique
Kaveh Azartash,1 Justin Kwan,2 Jerry R. Paugh,2 Andrew Loc Nguyen,3 James V. Jester,4 Enrico Gratton1
1Biomedical Engineering, University of California Irvine, Irvine, CA; 2Southern California College of Optometry, Fullerton, CA;
3California State University, Fullerton, CA; 4Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA
Purpose: The purpose of this work was to gather preliminary data in normals and dry eye subjects, using a new, non-
invasive imaging platform to measure the thickness of pre-corneal tear film.
Methods: Human subjects were screened for dry eye and classified as dry or normal. Tear film thickness over the inferior
paracentral cornea was measured using laser illumination and a complementary metal–oxide–semiconductor (CMOS)
camera. A previously developed mathematical model was used to calculate the thickness of the tear film by applying the
principle of spatial auto-correlation function (ACF).
Results: Mean tear film thickness values (±SD) were 3.05 μm (0.20) and 2.48 μm (0.32) on the initial visit for normals
(n=18) and dry eye subjects (n=22), respectively, and were significantly different (p<0.001, 2-sample t-test). Repeatability
was good between visit 1 and 2 for normals (intraclass correlation coefficient [ICC]=0.935) and dry eye subjects
(ICC=0.950). Tear film thickness increased above baseline for the dry eye subjects following viscous drop instillation and
remained significantly elevated for up to approximately 32 min (n=20; p<0.05 until 32 min; general linear mixed model
and Dunnett’s tests).
Conclusions: This technique for imaging the ocular surface appears to provide tear thickness values in agreement with
other non-invasive methods. Moreover, the technique can differentiate between normal and dry eye patient types.
Study of the precorneal tear film has enjoyed renewed
interest due to evidence that dry eye syndrome (DES) is a
common ophthalmic condition, potentially affecting 5% to
more than 30% of the adult population in the United States
[1], and one that adversely impacts the quality of life of those
who suffer from it [2]. One important trend in research has
been the development of non-invasive methods to
characterize the tear film. These include non-invasive stability
measures [3,4], approaches to quantify lipid layer thickness
[5] and behavior [6], and measurement of total tear film
thickness [7]. Tear film thickness in particular offers a
quantitative approach to characterize DES, wherein the
thickness is presumably less than under normal conditions due
to tear compositional or physiologic deficiencies leading to
instability and excessive evaporation. Moreover, tear film
thickness measurement offers an objective approach to
monitor the effect of dry eye treatment. An abnormally thin
tear film is of significance because it may possibly reflect a
state of hyperosmolarity of the ocular surface, which is
thought to cause damage and result in many of the dry eye
symptoms [8].
King-Smith et al. [9] used interferometry and by
evaluating the reflectance spectra from the ocular surface,
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were able to noninvasively quantify human tear film
thickness. They obtained measurements of approximately
3.0 µm for the normal human tear film [9]. While scientifically
sound, the reflectance spectra method is at present available
in very few laboratories, is technically complex and requires
relatively expensive equipment.
Another non-invasive method that has been applied to
tear film thickness measurement is optical coherence
tomography (OCT) [10]. OCT is an optical signal acquisition
and processing method that can be considered an
interferometric technique. OCT was first used to asses tear
film by Wang et al. [11,12] reporting values of approximately
3 µm, similar to those of King-Smith et al. [7,9,13,14] While
non-invasive, a concern relative to OCT is that the thickness
determination is indirect rather than direct measurement
[12].
In the current work a novel technique was applied to
quantify the thickness of the pre-corneal tear film in humans;
termed: Fluctuation Analysis by Spatial Image Correlation
(FASIC). Thus far, the method has demonstrated efficacy in
measurement of tear film thickness in animal models [15]
providing thickness values in agreement with prior
measurements. The system is robust, portable, low-cost (the
relative cost of this technique in its current configuration is
under $1,000.00.), and easy to operate. This technique
involves the quantitative assessment of periodic interference
patterns in a series of images, from which the ocular tear film
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thickness can be calculated using a mathematical model that
translates the spatial fluctuations into thickness information.
The aim of the investigation presented in this article was
to measure the thickness of the human tear film using FASIC.
This was a study to generate preliminary tear film thickness
data from normal (i.e., non dry eye) and dry eye subjects in a
clinic-based population. In addition, we examined the short-
term (i.e., one week) repeatability of the method in a single
setting and the temporal effect of a viscous lubricating eye
drop on tear film thickness.
METHODS
Instrumentation and the FASIC technique: A schematic of the
FASIC setup is shown in Figure 1. A 635 nm diode laser
(LXC6351AH; Lasermate, Pomona, CA), with less than 1mw
of power (0.7 mW–0.9 mW), was used as a monochromatic
coherent light source. The wavelength and power of this light
source were within the standards of Laser Institute of America
for eye safety [16]. The laser beam was collimated onto the
inferior cornea for all subjects, approximately mid-way
between the visual axis and the limbus at along the vertical
meridian and had a diameter of approximately 2 mm.
Therefore the measurements represent an average tear film
thickness across the illumination area. The incident angle,
which plays an important role in obtaining the true thickness
value, was approximately 12 degrees. The observation angle
was slightly greater than the incident angle in this apparatus.
The scattered and reflected light was focused back to a cMOS
camera (PL-A662-KIT; Pixelink, Ottawa, ON, Canada)
through an objective lens (Mitutoyo Compact CF 1×
Objective; Edmund Optics, Barrington, NJ). The objective
was coupled to the complementary metal–oxide–
semiconductor (CMOS) camera through an extender tube
having a length of 15 cm. To capture an image, the camera
assembly was focused 68 mm from the cornea. The camera
assembly and the light source were mounted onto an X-Y-Z
translational stage for backward/forward, up/down and
sideways movements. A stack of images (256×256 pixels
each) was streamed directly to a computer from the cMOS
camera through a Firewire cable with the exposure time set at
1 ms. The image size was chosen such that it covers the 2 mm
illuminating area on the eye. It also allows for capturing
images at a fast frame rate. This high frame rate allowed
capturing of fluctuations in the ocular surface at about 300 Hz
and to compensate for motion artifacts. For most of the
experiments 1,000 frames were collected for a total
acquisition time of approximately 4 s. The data acquisition
started approximately 1.5 s after the subject blinked. For the
Figure 1. An schematic of the physical
principles and the components in
FASIC setup. The low-power, 635 CW
laser (L) illuminates the ocular surface
at an incident angle of θ. The cMOS
camera (C) is connected to a 1×
objective lens (O) through an extender
tube (E) captures the images at an
observation angle of β.
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thickness analysis, the first 500 frames were analyzed. This
means that only the thickness data from 1 to 2 s following eye
opening were measured, and the data that were analyzed
belonged to 3 s following a blink; less than the average inter-
blink interval. For subjects with approximately 3 s tear break-
up time (TBUT), the data were analyzed such that the FASIC
measurement does not go over the TBUT.
Prior to the study, the system was calibrated using
parylene films fabricated on a silicon substrate. The thickness
obtained with the FASIC approach measured film thickness
accurately compared against profilometer measurements.
Using these films in the range of tear film thickness the FASIC
method demonstrated a coefficient of variation (COV) of
approximately of 0.20 to 0.35% (4.92 and 2.90 μm thickness
standards, respectively). In the human tear film, the COV was
much greater, ranging from about 6.7 to 13.1% for the non-
dry eye and dry eye subjects, respectively (visit 1). However,
this relatively small variability allowed meaningful
differences to be uncovered under the several test conditions.
Spatial autocorrelation and physical principles: Spatial
autocorrelation is a mathematical operation that measures and
evaluates the degree of dependency of a set of data with itself.
Petersen et al. [17] pioneered the application of this statistical
analysis to the imaging and microscopy community. The
spatial autocorrelation relationship is given by [17]:
Gs(ξ, ψ) =
I (x, y)I (x + ξ, y + ψ) x ,y
I (x, y) x ,y2
− 1
where I(x,y) represent the image intensity, ξ and ψ are the
spatial increments in the x and y directions, respectively, and
the angle bracket indicates the average over all the spatial
locations in both x and y directions. The principles of
autocorrelation analysis have been widely accepted in the
imaging and microscopy community [18-21]. A raw camera
image is shown in Figure 2. This figure illustrates various
families of periodic fringes with different spacing and
orientation. The features in the image are difficult to be
discriminated by the human eye.
The periodic pattern that is observed at the ocular surface,
originates from interference within the tear film and from
scattering at the surface of the tear film. Existence of
convoluted features such as lines, dots and other structures
makes the camera image in general complex, although it
Figure 2. This figure shows the raw
camera image. In this image multiple
interference patterns are apparent with
different spacing, sizes and orientations.
The period of these fringes is extracted
by applying the spatial autocorrelation
analysis and used in calculating the
thickness of the tear film.
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follows the basic dependency on tear film thickness. These
complex features are not picked up by simple inspection of
the images and therefore, the pattern is only analyzed in the
autocorrelation function and after selecting the correct
periodic pattern. The factors affecting the periodic part of the
spatial autocorrelation function have been experimentally
determined and verified to depend on the inverse of the
thickness of the film. In a previous work [15], it was shown
that the thickness then can be calculated by:
t = KnPsin (θ)
where n is the refractive index of the medium which is
assumed to be 1.336 [22], and θ is the incident angle and K is
a constant and was empirically obtained and includes the
wavelength of the light as well. P is the period of the fringes
available in the raw camera data which is calculated using the
auto-correlation function (ACF).
Human tear thickness studies:
Study population—Normal (non-dry eye) and dry eye
subjects were recruited by word of mouth and sourced from
the existing dry eye database of the Southern California
College of Optometry (Fullerton, CA). Thus, this represented
a clinic-based sample. Subjects were designated as not having
dry eye (normal) or having dry eye based on symptoms, tear
stability, and corneal and/or conjunctival staining (see below).
All subjects were 18 years of age or older. Major inclusion
criteria included the ability to return for the repeatability visit
within 7±2 days and willingness to discontinue soft contact
lens wear or the use of topical drops 2 days before each
measurement visit. Soft contact lens wearers were included,
although it is not known whether lens wear affects tear
thickness.
Major exclusion criteria included ocular surgery within
the previous six months, evidence of active ocular infection,
use of topical ocular medications other than artificial tears,
rigid gas permeable contact lens wearers, and individuals with
punctual plugs. Normals, and dry eye subjects who were mild,
moderate, or severe were enrolled. Severity was assigned
based on the worst sector corneal fluorescein staining grade
of any of the 10 sectors for either eye according to the Efron
scale [23] during the eligibility visit.
All subjects enrolled in the study were advised not to use
topical eyedrops two days before each thickness
determination (initial and repeatability visit) and contact lens
wearers were advised to discontinue lens wear for two days
before tear thickness determinations.
With the exception of the prohibition of pre-visit topical
eyedrops, the subjects were assessed concurrent with existing
dry eye management, which could have included omega 3
supplementation or use of the tetracycline drugs for
meibomian gland dysfunction.
Study procedures: Informed, written consent was obtained
before initiating any study procedures. This study adhered to
the tenets of the Declaration of Helsinki and was assigned
clinical trial number NCT01014780.
Each subject had 3 visits to the clinic: an initial eligibility
and characterization visit, and two quantitative tear thickness
measurement visits with FASIC. The major experiments were
tear thickness repeatability in normals and dry eye subjects,
and a retention of effect study in the dry eye subjects using a
viscous topical formulation (see below for details). All
subjects were asked to return for a repeatability visit within
one week (7 days), ±2 days. Since there is diurnal variation in
several tear parameters, including stability [24,25], we re-
measured tear thickness within the same one-half day (i.e.,
either morning or afternoon) as the initial assessment.
The subjects were classified as normal or having dry eye
at the eligibility visit using a battery of tests. A medical history
was taken, and dry eye symptoms were determined using the
Schein questionnaire. Although there are several dry eye
instruments available, we prefer the Schein survey since it is
rapid (taking about 1 min to answer and score), was validated
originally [26] and more recently in the modified form [27]
against clinical diagnosis and has demonstrated repeatability
in a treatment trial [28]. The original Schein questionnaire
[26] was modified by adding a category of “never,” and
assigning numerical values to each category (i.e., never=0;
rarely=1, sometimes=2, often=3, all of the time=4). This
allowed use of a semi-continuous numerical scale (0–24), for
which a cut-point of 7 or greater for dry eye has been
established [27].
Fluorescein tear breakup time (TBUT) was undertaken
using liquid fluorescein (5.0 μl of 2.0% instilled using a
micropipette) as part of the sequence used by Pflugfelder et
al. [29] to assess TBUT, cornea staining and tear clearance.
Although a historical breakpoint for fluorescein BUT has been
<10 s [3,30] this criterion was reduced to <7 s by us for two
major reasons.
First, the older studies used larger volumes of liquid
fluorescein [31,32] and it has been demonstrated that
instillation volume influences TBUT values [33]. Using
5.0 μl of 2.0% dye, Pflugfelder et al. [29] and Abelson et al.
[34] have found TBUT values for normals in the range of 7 s,
and have used breakpoints for classifying subjects as “dry” of
≤7 s. Moreover, Sullivan et al. [35] also using 5 μl of 2%
sodium fluorescein, suggested a breakpoint of <7 s for a “dry”
subject classification.
Another reason for the use of a TBUT breakpoint of ≤7.0
s was that it represented a conservative value for inclusion of
dry subjects. Since this was a preliminary study, we
endeavored to make certain that our dry breakpoint clearly
differentiated normals from dry eye subjects, so that tear
thickness differences, if present, would be observed.
We used a biomicroscope set at 16× and a yellow barrier
filter to enhance observation of the initial dark spot (defined
as the first change following a normal blink). The subject was
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instructed to blink normally three times, then to hold the
eyelids open. Following the measurement, the eyelids were
closed for 30 s, then the TBUT measured in the fellow eye.
Each eye was measured three times in this alternating manner,
and the mean value for each eye calculated.
Following TBUT determination, corneal staining was
assessed using the Efron scale [23],modified with a five-sector
corneal overlay [30,36], the bio-microscope set at 16×
magnification, and the use of a yellow barrier filter. Corneal
staining was graded using a 0–4 scale in 0.1 unit increments
for five zones for each cornea. The worst sector score and the
total staining score (sum of 0–4 scores for each of five sectors)
for each eye were recorded, similar to that advocated by
Appendix 5 of the DEWS Diagnostic subcommittee report
[37]. Rose bengal conjunctival staining was assessed
according to the NEI/Industry Workshop report (6
conjunctival zones), also using liquid dye [30] (3 μl of 1.0%
non-preserved rose bengal instilled using a micropipette).
The criteria for determination of whether a subject had
dry eye were as follows. At least 2 out of 3 criteria had to be
met. Schein symptom questionnaire; dry if scored >7 of 24
maximum
• TBUT, average of three determinations; dry if ≤7 s
since several studies have found normal TBUTs of less
than 10 s [4,34,38-40];
• Fluorescein corneal staining, five zones; dry if ≥4
of 20 maximum (20%) OR rose bengal conjunctival
staining, six zones (excludes cornea); dry is ≥4 of 24
maximum (17%) [30]
Two of the three criteria had to be satisfied (i.e.,
symptoms and staining, TBUT and staining, etc.) for the
subject to be considered dry. Only one eye at each subject was
used to collect tear thickness data, and always the same eye at
both visits. The eye chosen was the eye that demonstrated the
worst staining (0–4 scale), in any of the five sectors of either
cornea [30]. Dry eye severity was based on the DEWS 2007
definition and classification subcommittee report [41]. The
severity was assigned a Level 1–4, based on multiple signs
and symptoms.
Tear thickness measurement: The apparatus was mounted
onto a table which was fastened to a headrest to stabilize the
subject’s head (Figure 3). The subject was seated and
instructed to fixate a target at approximately a 45 degree angle
above horizontal. The laser and detector apparatus was aimed
at the mid-peripheral inferior cornea for image capture. The
subjects were instructed to blink normally three times to
provide a consistent tear thickness, then the blink was
suspended and images gathered for approximately 4 s.
Thickness effect of a viscous eyedrop: To determine the length
of time that a viscous artificial tear solution (Refresh Liquigel;
Allergan, Irvine, CA) containing 1% carboxymethylcellulose
as the primary viscolyzer might elevate tear film thickness, a
25 μl drop was instilled into the subject’s inferior fornix [42]
using a positive displacement pipette. Tear thickness was
monitored every 2 min post-instillation until 40 min post-
instillation. For each measurement the subject blinked
normally three times, and then held the eyelids open for
approximately 4 s.
Safety monitoring: Visual acuity was re-checked as one safety
measure at ten minutes post-thickness measurement for
subjects at Visit 1. The acuity could not be checked at Visit 2
since the drop was instilled immediately following the
baseline thickness measurement. Visual acuity was assessed
using a calibrated Snellen chart to monitor potential vision
changes, with decrements greater than 2 letters considered
significant. In addition, the inferior cornea in the region of the
measurement was examined following the thickness
measurement using slit-lamp biomicroscopy to assess cornea
swelling or injury. Minimal laser injuries to the cornea have
been defined as inducing a small white area involving the
epithelium that develops within 10 min of exposure [16]. We
examined each subject for the white spot, and for corneal
staining post-thickness measurement following instillation of
2.0 μl of 1.0% non-preserved sodium fluorescein with use of
a yellow barrier filter and the biomicroscope.
Data analysis: The normal and dry eye tear thickness data
were compared using 2-sample t-tests at Visits 1 and 2 of
FASIC measurements. Intraclass correlation was used to
examine repeatability, Visit 1 to Visit 2 for the normal and dry
samples. We obtained the ICC from SPSS software (version
11.0; SPSS Inc.) using the one-way random model. We
selected this model because we treated subjects as random and
visit times as fixed. Correlational analysis of thickness relative
to both Schein symptom scores (0–24 scale) and total corneal
staining (0–20 scale) was undertaken. Preliminary tear
thickness sensitivity and specificity analysis was undertaken
using a receiver operating characteristic (ROC) approach
[37]. A linear mixed model was used to compare the tear
thickness over time for the retention of effect experiment at
Visit 2. The subjects were treated as the random effect (as they
were selected from a much larger population) and all
treatments were fixed. Minitab software was used this analysis
(version 15.0 from Minitab Inc.). Dunnetts Simultaneous
Tests (corrects for multiple comparisons) were used to
determine significant differences from the baseline, pre-
instillation tear thickness.
RESULTS
General results: The subject demographics for this study
sample are summarized in Table 1. Forty subjects completed
both visits, 22 dry eye subjects and 18 without dry eye. Of
these, there were 19 males and 21 females, with more females
in the dry group and all six of the soft lens wearers in the dry
eye group. Overall, the ethnic groups are representative of the
local population.
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Summary tear film data are also included in Table 1.
Relative to dry eye severity, based on worst sector fluorescein
staining, the 22 dry eye subjects fell into groups of 3 at trace,
14 who were mild, 5 moderate, and none in the severe
category.
Regarding safety and comfort, the procedure was well
tolerated in all subjects. There were no instances of visual
acuity loss, visible corneal changes [16] or adnexal irritation.
There were no occurrences of excess (i.e., beyond that present
at the eligibility visit) corneal staining in the area of thickness
measurement (using 2.0 μl of 1.0% NaFl, 10 min post-FASIC
measurement).
Tear film thickness in normals and dry eye subjects: We first
considered whether the tear film thickness values were
different for subjects with normal eyes compared to the dry
eye group at visits 1 and 2 of FASIC measurements. For the
first quantitative visit, the measured tear film thickness values
averaged 3.05±0.21 μm and 2.48±0.27 μm for normals (n=18)
and dry eye subjects (n=22), respectively. These thicknesses
were significantly different (2-sample t-test, p<0.001). At the
second (repeatability) visit, mean tear thickness values were
3.06±0.18 μm and 2.46±0.25 μm for normals (n=18) and dry
eye subjects (n=22), respectively, and were also significantly
different (two-sample t-test, p<0.001). Figure 4 shows the
histogram of the individual tear film thickness values.
The repeatability of the thickness values in normal and
dry eye subjects for the two visits was evaluated by intraclass
correlation coefficient (ICC). ICC values of 0.935 and 0.950
were obtained for the normal and dry eye groups, respectively.
These results demonstrate good repeatability of this
technique. Figure 5 displays the relative correlation between
the data from the two visits with this imaging platform.
For a diagnostic method, the Dry Eye Workshop has
recommended assessing the test sensitivity (ability to detect
disease) and specificity (the ability to correctly identify those
without disease) for measures of dry eye [37]. Since we
diagnosed dry eye disease using conventional tests, tear
thickness could be analyzed for these parameters. We plotted
sensitivity against 1–specificity to generate a receiver
operating characteristic (ROC) curve as shown in Figure 6.
Inspection of the ROC curve provided an ACU of 0.886 and
suggested an optimal cut point for tear thickness of 2.75 μm.
The corresponding sensitivity and specificity were 0.864 and
0.944, respectively.
Figure 3. This figure displays the optical
apparatus used for human tear film
thickness measurements. The laser and
the camera assembly were placed on
mechanical stages equipped with X-Y-
Z movement. The imaging system is
mounted onto a track for scanning
purposes. Subjects placed their head on
the chin-rest and maintained a constant
focal length with respect to the camera
assembly. Data were streamed to a
computer for further computational
analysis.
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Correlational analysis was undertaken at both visits to
compare tear thickness against total corneal staining score (0–
20 scale), Schein symptom score (0–24 scale) and tear
stability (TBUT). For total staining, moderate correlation was
found (drys only; Pearson’s R of −0.574 (p=0.005) and −0.424
(p=0.049) for Visits 1 and 2, respectively. No relationship was
found for tear thickness and Schein score (drys only;
Pearson’s R=0.120 [p=0.594] and R=0.033 [p=0.885] for
Visits 1 and 2, respectively). For tear stability, we found slight
negative correlations between TBUT and tear thickness for
normals at both visits, and slight positive correlations for dry
eyes, but none of the relationships was statistically significant.
However, correlational analysis using all subjects (n=40) for
tear thickness versus tear stability (TBUT) found a moderate
positive correlation (Pearson’s values: R=0.419 and 0.412 for
visits 1 and 2, respectively) that were highly statistically
TABLE 1. SAMPLE DEMOGRAPHICS AND TEAR FILM DATA.
 Sex Ethnicity  
  
Age Male Female
Schein
score
(0–24)
TBUT (s) Cornea
l stain
(0–20)
Normal
eyes
(n=18)*
12 6 10 5 3 0    
Median 26.5       3.0 7.1 0.85
Mean 29.0       3.4 8.0 1.3
SD 8.3       1.8 3.2 1.5
Dry eyes
(n=22)**
7 15 10 5 5 2   
Median 32.0       9.5 4.2 5.6
Mean 38.8       9.3 4.6 5.2
SD 13.8       4.0 2.5 2.2
        *Did not satisfy more than one of the dry criteria (i.e., symptoms >7/24, TBUT ≤7.0 s, or corneal staining ≥4.0 on a 0–20 scale).
        **Severity designation is described in Methods and is assigned a level 1–4 based on the DEWS 2007 Definition and Classification
        report [41]. Thus, 3 subjects were Level 1, 12 Level 2, 7 Level 3, and none were Level 4.
Figure 4. Human tear thickness data for
normals (n=18) and dry eye subjects
(n=22) at Visit 1.
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Caucasian Asian Hispanic     Afri. Amer.
significant (p=0.007 and p=0.008 for visits 1 and 2,
respectively). This suggests that even with a modest overall
sample size that as tear stability increases, so does tear
thickness, as might be expected.
Thickness effect of a viscous eyedrop: The effect on tear
thickness of a viscous topical formulation was examined in
the dry eye subject sample (n=19). Following a single 25 µl
drop instillation into the inferior fornix, tear thickness was
monitored every 2 min until 40 min post-instillation.
Figure 7 displays the retention of effect data obtained.
The phrase “retention of effect” is used since we measured the
length of time that a beneficial effect (i.e., a thickness
increase) was evident, not the direct residence time of the
drop. The mean baseline thickness was 2.49±0.31 µm. Tear
film thickness increased to a mean value of 5.95±0.68 µm at
measurement number 1 with the maximum and minimum
value of 6.85 µm and 4.62 µm, respectively. Tear film
thickness decreased over time and recovered to baseline levels
in 16 of the subjects. Tear thickness became less than the
Figure 5. Relative correlation between
the two FASIC visits is shown.
Figure 6. Receiver operating
characteristic curve (ROC) for tear
thickness using data from Visit 1. The
AUC is 0.886. At a cut-point for tear
thickness of ≤2.75 μm, to diagnose dry
eye, the test sensitivity is 0.86, and the
specificity is 0.94.
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baseline value in 1 of the subjects in this study. Tear thickness
was statistically significantly different (greater) than baseline
until 32 min post-instillation (Dunnett’s simultaneous tests;
p=0.047 at 32 min compared baseline).
The retention time data were fitted with a single
exponential function using the method of least-squares to find
the decay time in each data set. Figure 8 shows the averaged
data for each time point fitted with a single exponential
function. This set of data had a time-constant value of
10.71±4.05 min and an amplitude value of 5.03±1.54. As can
be seen, the data exhibits a true exponential behavior.
DISCUSSION
We investigated the ability of a recently described [15], non-
invasive method, based on fluctuation analysis using spatial
image correlation, to estimate the thickness of the human tear
film. The method requires relatively inexpensive equipment
and appears safe for multiple measurements of the tear film
since we observed no corneal distress or change in visual
acuity following the procedure. The mean values found for
non-dry eye subjects were approximately 3.1 um (±0.2) for
both visits (n=18). These are in good agreement with the data
of King Smith and coworkers [9,13] who found a mean value
Figure 7. This plot represents the
changes in tear film thickness by subject
as a function of time upon instillation of
Refresh Liquigel (Allergan, Irvine, CA).
These data were used to calculate the
mean retention of effect time for the
sample, 32 min, to become statistically
indistinguishable from the mean
baseline tear thickness.
Figure 8. Individual data sets from every
subject have been fitted with the single
exponential function. A, B: Show two
typical data sets along with their single
exponential fittings. Decay constant was
calculated for every subject and an
average value (±STD) 9.52±2.02 of was
obtained.
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of approximately 3.0 µm in normal humans, also using a
direct, non-invasive method. Moreover, at both visits we
found a statistically significant difference in tear thickness
(p<0.001 at visit 1 and 2) between dry eye subjects (~2.5 µm,
n=22) compared to non-dry eye individuals. For both non-dry
eye subjects and dry eye subjects the short-term (within one
week) repeatability was very high (ICC of 0.94 and 0.95,
respectively).
The thickness comparison data and the repeatability data
for the two subject groups demonstrated highly significant
differences due to the sensitivity and specificity of this
quantitative imaging technique.
We explored the diagnostic test efficacy of tear thickness
measurement using the FASIC approach to differentiate non-
dry eyes from those with dry eye using the approach suggested
by the recent DEWS report [37]. We used standard tests (i.e.,
the presence or absence of irritation symptoms, fluorescein
tear stability, corneal and conjunctival staining) to classify
subjects as dry or non-dry, then examined the sensitivity of
tear thickness to characterize these subjects as dry or non-dry.
The sensitivity and specificity data used to generate the ROC
curve (Figure 6) suggest that thickness can indicate dry eye at
a cut-point of thickness ≤2.75 µm with a sensitivity of 86%
and a specificity of 94%. These test efficacy numbers are quite
promising, although they need to be verified in an independent
sample of normal and dry eye subjects [37].
The goal of topical therapy in dry eye is to relieve
symptoms in conjunction with potentially replacing deficient
components (e.g, aqueous fluid) so that the tear film is
thickened and stabilized in the short-term to provide healing
of the ocular surface over time. We undertook a brief study of
the effect of a viscous topical drop and examined the thickness
changes occurring and the length of time that the thickness
effect could be observed. This latter phenomenon is referred
to as the retention of effect rather than a direct estimate of
residence, or ocular surface dwell time.
Our results suggest that, compared to the baseline tear
thickness in the dry eye group (mean=2.48±0.32 μm), the tear
film becomes significantly thicker at 2 min post-instillation
(mean=5.95±0.68 μm) and remains significantly thicker
(p<0.05) until 32 min post-instillation. This retention of effect
time is in agreement with the direct residence time reported
earlier (approximately 41 min [43]) for the same artificial tear.
Moreover, the time of approximately 32 min of beneficial
effect is similar to that found for non-invasive tear stability
when a thickened artificial tear was examined in dry eye
subjects [3].
Future rsearch: This work was a preliminary study that
provided initial tear film thickness data. However several
issues remain that require further consideration. One concern
is the confounding effect of subject age, sex, and prior contact
lens wear. While age is expected to influence tear thickness,
the potential differences due to sex and contact lens wear
require studies with a larger number of subjects. Other
potentially important issues are the severity of the dry eye
condition, and the sub-type of dry eye (i.e., meibomian gland
dysfunction compared to aqueous tear deficiency). Similarly,
a fundamental question is whether various dry eye etiologies
result in differing tear film thicknesses.
Given the relatively small bulk of the apparatus used in
this study, future research could investigate tear thickness in
other areas of the cornea including: central, superior, nasal,
temporal, and inferior regions. The scanning can be done
simply by moving the imaging system along the ocular
surface.
Another application of the methodology could be in drug
delivery. Drug delivery vehicles could be evaluated for
retention of effect, to determine whether a given formulation
provides efficacy in delivering medication into the anterior
chamber. Healthy normals should be evaluated as controls, as
well as diseased subjects, since patients with intraocular
conditions may exhibit normal external ocular health. Healthy
normals could also participate in future studies to explore the
biophysics characteristics of tear film. In this technique, a low
power 635 nm laser was used and we did not detect obvious
reflex tearing or other untoward subject behavior. While no
adverse effects were detected it is possible that the intensity
of the light could have physiologic effects on subjects such as
increased blink rate and increased tearing. Future studies need
to evaluate this possibility along with assessing the
application of a longer wavelength (i.e., in the infrared range)
light source that may produce fewer physiologic effects.
Conclusions: In this work the thickness of a human pre-
corneal tear film was quantified. The residence time of a
lubricating eye drop (Refresh Liquigel; Allergan, Irvine, CA)
was also studied on subjects with dry eye. Our measurements
revealed the details of the changes in thickness as a function
of time.
The FASIC technique appears to provide valid human
tear thickness values and expected thinner values in dry eye.
It is repeatable in both normals and dry eye subjects over a
short time frame, and appears to provide good test efficacy
when used as a diagnostic test for dry eye. Moreover, tear
thickness appears to be an indicator of topical formulation
retention of effect by being able to monitor thickness changes
over time. As such it could be used to monitor both the short-
term efficacy of dry eye treatment preparations and to
determine whether tear thickness returns to normal following
longer-term treatment.
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